Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium
Conditions
Interventions
Intervention1: Injection.Tranexamic acid 1gm: â?¢ 100 Pregnant women prior to induction and early labor will be examined by taking informed and written consent of the patient. â?¢ In each patient, t
Sponsors
Gamidi Anusha
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age > 19 years and 2) Spontaneous vaginal delivery 3) Induced vaginal delivery 4) Assisted vaginal delivery 5) Term > 35 weeks of gestation 6) Singleton pregnancy
Exclusion criteria
Exclusion criteria: 1) History of venous (deep vein thrombosis and/or pulmonary embolism) or arterial (angina pectoris,myocardial infarction, stroke) thrombosis 2) History of epilepsy or seizure 3) Any known cardiovascular, renal, or liver disorders 4) History of Autoimmune disease 5) History of Sickle cell disease 6) History of Severe hemorrhagic disease 7) Placenta previa 8) Abnormally invasive placenta (placenta accreta/increta/percreta) 9) Abruptio placentae 10) Eclampsia, HELLP syndrome 11) Multiple pregnancy 12) In utero fetal death 13) Administration of low-molecular-weight heparin or antiplatelet agents during the week before delivery 14) PROMâ??patients referred from periphery with PROM were excluded as the chances of chorioamnionitis were more due to repeated internal examinations 15) Prolonged and obstructed labour
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Injection Tranexamic acid administration along with oxytocin can reduce obstetric blood lossTimepoint: 24 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Injection tranexamic acid administration along with oxytocin can reduce obsetric blood lossTimepoint: 24 months | — |
Countries
India
Contacts
Public ContactGamidi Anusha
Dr.pinnamaneni siddhartha institute of medical sciences
Outcome results
None listed